-
公开(公告)号:US20110263479A1
公开(公告)日:2011-10-27
申请号:US13064881
申请日:2011-04-22
申请人: Øyvind Jacobsen , Pål Rongved , Jo Klaveness
发明人: Øyvind Jacobsen , Pål Rongved , Jo Klaveness
CPC分类号: C07K5/1024 , A61K38/00 , A61K38/03 , C07K1/107 , C07K1/1072 , C07K1/1075 , C07K4/00 , C07K7/06
摘要: A peptide which can adopt a 310-helical conformation in which the side chains of two amino acid residues in the peptide backbone are linked by a group comprising an aromatic 5-membered ring.
摘要翻译: 可以采用310螺旋构象的肽,其中肽主链中两个氨基酸残基的侧链通过包含芳香族5元环的基团连接。
-
公开(公告)号:US20110052503A1
公开(公告)日:2011-03-03
申请号:US12808318
申请日:2008-12-22
申请人: Torsten Almen , Bjarne Brudeli , Fred Kjellson , Jo Klaveness , Jian-Sheng Wang
发明人: Torsten Almen , Bjarne Brudeli , Fred Kjellson , Jo Klaveness , Jian-Sheng Wang
CPC分类号: A61K49/0438 , A61K31/03 , A61K31/75 , A61K31/765 , A61K31/785 , A61K45/06 , A61K49/0461 , A61L29/18 , A61K2300/00
摘要: The present invention provides a radio-opaque composition comprising a cleavable, preferably enzymatically-cleavable, derivative of a physiologically tolerable organoiodine compound and a non-acrylic polymer wherein said derivative is incorporated in said non-acrylic polymer.
摘要翻译: 本发明提供一种不透射线组合物,其包含生理上可耐受的有机碘化合物和非丙烯酸类聚合物的可裂解,优选可酶切割的衍生物,其中所述衍生物掺入所述非丙烯酸类聚合物中。
-
公开(公告)号:US07892522B2
公开(公告)日:2011-02-22
申请号:US09950985
申请日:2001-09-13
申请人: David Johnson , Jonny Østensen , Morten Eriksen , Audun Tornes , Sigmund Frigstad , Harald Dugstad , Jo Klaveness , Pål Rongved , Roald Skurtveit , Jorunn Brænden
发明人: David Johnson , Jonny Østensen , Morten Eriksen , Audun Tornes , Sigmund Frigstad , Harald Dugstad , Jo Klaveness , Pål Rongved , Roald Skurtveit , Jorunn Brænden
CPC分类号: A61K49/223
摘要: Ultrasound contrast agents comprising microbubbles of biocompatible gas, e.g. a sulphur halide or a perfluorocarbon, stabilized by opsonisable amphiphilic material, e.g. a membrane-forming lipid such as a phospholipid, especially a negatively charged phospholipid such as a phosphatidylserine, may exhibit prolonged contrast-generating residence time in the liver following intravenous administration.
摘要翻译: 超声造影剂包括生物相容性气体的微泡,例如 卤化物或全氟化碳,通过可调节的两亲性材料稳定,例如。 成膜脂质如磷脂,特别是带负电荷的磷脂如磷脂酰丝氨酸,可以在静脉内给药后在肝脏中产生延长的对比度产生停留时间。
-
公开(公告)号:US20110038953A1
公开(公告)日:2011-02-17
申请号:US12913508
申请日:2010-10-27
IPC分类号: A61K33/14 , A61K31/197 , A61P29/00 , A61K31/60 , A61K31/375 , A61K31/192 , A61K31/196 , A61K31/20 , A61K31/194 , A61K31/198 , A61K31/195
CPC分类号: A61K33/14 , A61K31/192 , A61K31/194 , A61K31/196 , A61K31/198 , A61K31/20 , A61K31/28 , A61K31/375 , A61K31/60 , A61K33/24 , Y10S514/936 , Y10S514/946 , Y10S514/947
摘要: The invention provides a method of treatment of a human or non-human subject to combat sub-dermal soft tissue pain therein, said method comprising administering to a subject in need thereof an effective amount of a physiologically tolerable strontium compound.
摘要翻译: 本发明提供一种治疗人或非人受试者的方法,以对抗其中的皮下软组织疼痛,所述方法包括向有需要的受试者施用有效量的生理上可耐受的锶化合物。
-
公开(公告)号:US20100047360A1
公开(公告)日:2010-02-25
申请号:US12225060
申请日:2007-03-14
申请人: Jo Klaveness , Geir Havard Kvalheim
发明人: Jo Klaveness , Geir Havard Kvalheim
IPC分类号: C07C211/01 , A61K31/132 , A61K31/16 , C07C229/00 , A61K31/205 , A61K38/43 , A61K35/12 , A61K36/00 , A61K38/39 , A61P17/06
CPC分类号: A61K31/132
摘要: The present invention provides unbranched aliphatic polyamines for use in therapy, particularly for use in the treatment of psoriasis and compositions containing polyamines.
摘要翻译: 本发明提供了用于治疗的非支链脂族多胺,特别是用于治疗银屑病和含有多胺的组合物。
-
公开(公告)号:US07629383B2
公开(公告)日:2009-12-08
申请号:US10496328
申请日:2002-11-22
申请人: Jo Klaveness
发明人: Jo Klaveness
IPC分类号: A61K31/225 , C07C69/52
CPC分类号: A61K31/225 , A61K31/23 , C07C69/34 , C07C69/48 , C07C69/96
摘要: The invention provides acyloxymethyl esters of C6-14 alkane-dicarboxylic acids, or physiologically tolerable salts or esters thereof, for use in medicine as therapeutic or prophylactic agents.
摘要翻译: 本发明提供了用作医药或预防药物的C 6-14烷烃二羧酸的酰氧基甲基酯或其生理上可耐受的盐或酯。
-
公开(公告)号:US20080293665A1
公开(公告)日:2008-11-27
申请号:US11629908
申请日:2005-06-20
申请人: Kjell Undheim , Kjetil Tasken , Jo Klaveness , Geir Langli , Vidar Bjornstad
发明人: Kjell Undheim , Kjetil Tasken , Jo Klaveness , Geir Langli , Vidar Bjornstad
IPC分类号: A61K31/7076 , C07H19/20 , G01N33/50 , A61P37/00
CPC分类号: C07H19/213 , Y10T436/143333
摘要: This invention provides novel 8-carbyl substituted Camps (adenosine 3′,5′-cyclic monophosphorothioate) and a novel procedures for the preparation of 8-Br-cAMP, a key starting material.
摘要翻译: 本发明提供新的8-羰基取代的营养素(腺苷3',5'-环状单硫代磷酸酯)和制备8-Br-cAMP(一种关键起始物质)的新方法。
-
公开(公告)号:US20080287390A1
公开(公告)日:2008-11-20
申请号:US12007694
申请日:2008-01-14
申请人: Enok Tjotta , Jo Klaveness
发明人: Enok Tjotta , Jo Klaveness
IPC分类号: A61K31/7064 , A61K31/4152 , A61K31/496 , A61P31/12 , A61K31/551 , A61K31/7076
CPC分类号: C07D231/32 , A61K31/415 , A61K31/4152 , A61K31/495 , A61K31/522 , A61K31/55 , A61K31/551 , A61K31/70 , A61K31/7076 , A61K45/06 , C07D231/30 , A61K2300/00
摘要: The invention provides the use of an optionally hydroxyl-protected 4-hydroxy or hydroperoxy-3,5-dioxopyrazolidine or an equivalent wherein a pyrazolidine ring attached oxygen is replaced by a sulphur, or a physiologically acceptable salt thereof, for the manufacture of a medicament for use in drug therapy or prophylaxis. Additionally, the invention provides a method of combating HIV infection which comprises administering to an HIV-infected patient a T-lymphocyte growth suppressing agent, preferably a pyrazolidinol, in an amount sufficient to suppress T-lymphocyte growth in said patient for a period sufficient to reduce the T-lymphocyte concentration in lymph nodes in said patient.
摘要翻译: 本发明提供任选羟基保护的4-羟基或氢过氧-3,5-二氧杂吡唑烷或其等价物,其中连接有吡唑烷环的氧被硫或其生理上可接受的盐替代,用于制备药物 用于药物治疗或预防。 另外,本发明提供了一种抗艾滋病毒感染的方法,其包括以足以抑制所述患者的T淋巴细胞生长的量向HIV感染的患者施用T淋巴细胞生长抑制剂,优选吡唑烷醇,时间足以 降低患者淋巴结中的T淋巴细胞浓度。
-
79.
公开(公告)号:US20080064752A1
公开(公告)日:2008-03-13
申请号:US10594361
申请日:2005-03-29
申请人: Jon Erik Braenden , Aslak Godal , Nils Olav Nilsen , Jo Klaveness
发明人: Jon Erik Braenden , Aslak Godal , Nils Olav Nilsen , Jo Klaveness
IPC分类号: A61K31/195 , A61P31/00 , C07C229/22 , G01N21/76
CPC分类号: A61K41/0061 , C07C229/22
摘要: The present invention provides an acid addition salt of 5-aminolevulinic acid (5-ALA) or of a 5-ALA derivative (e.g. a 5-ALA ester) with an acid which has a pKa of about 5 or less, preferably about 3 or less, with the proviso that the acid is other than hydrochloric acid. Particularly preferred salts are those derived from acids selected from the group comprising sulphonic acid and its derivatives, hydrobromic acid, sulfuric acid, nitric acid and phosphoric acid. The salts in accordance with the invention are particularly suitable for use as photosensitizing agents in diagnosis and photochemotherapy of disorders or abnormalities of external or internal surfaces of the body.
摘要翻译: 本发明提供5-氨基乙酰丙酸(5-ALA)或5-ALA衍生物(例如5-ALA酯)与酸的加成盐,所述酸的pKa为约5或更小,优选约3或 较少,条件是酸不是盐酸。 特别优选的盐是衍生自选自磺酸及其衍生物,氢溴酸,硫酸,硝酸和磷酸的酸的酸。 根据本发明的盐特别适用于诊断和光化学治疗身体的外表面或内表面的病症或异常的光敏剂。
-
公开(公告)号:US20070258904A1
公开(公告)日:2007-11-08
申请号:US10582679
申请日:2004-12-17
申请人: Jo Klaveness , Edvin Johannesen , Helge Tolleshaug
发明人: Jo Klaveness , Edvin Johannesen , Helge Tolleshaug
CPC分类号: A61K49/0032 , A61K49/0043 , A61K49/0052 , A61K49/0056
摘要: The invention provides contrast agents for optical imaging of oesophageal cancer and Barrett's oesophagus in patients. The contrast agents may be used in diagnosis of oesophageal cancer and Barrett's oesophagus, for follow up of progress in disease development, for follow up of treatment of oesophageal cancer and Barrett's oesophagus and for surgical guidance. Further, the invention provides methods for optical imaging of oesophageal cancer and Barrett's oesophagus in patients.
摘要翻译: 本发明提供了用于患者食管癌和Barrett食管的光学成像的造影剂。 造影剂可用于食管癌和巴雷特食管的诊断,用于跟踪疾病发展进展,跟进食管癌和巴雷特食管的治疗以及手术指导。 此外,本发明提供了食管癌和Barrett食管的光学成像方法。
-
-
-
-
-
-
-
-
-